Assessment of Combined Karyotype Analysis and Chromosome Microarray Analysis in Prenatal Diagnosis: A Cohort Study of 3710 Pregnancies

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Sample type</td><td class="align_center">Sample numbers</td><td class="align_center">Karyotype abnormalities</td><td class="align_center">CMA abnormalities</td><td class="align_center">Karyotype + CMA abnormalities</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">Amniotic fluid</td><td class="align_center">3710</td><td class="align_center">201 (5.41%)</td><td class="align_center">340 (9.14%)</td><td class="align_center">352 (9.49%)</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Diagnostic yields in 3710 prenatal samples by karyotype analysis and CMA.</div>

Genetics Research

tab1

Table 1

Table 1: Assessment of Combined Karyotype Analysis and Chromosome Microarray Analysis in Prenatal Diagnosis: A Cohort Study of 3710 Pregnancies 